| Item Type | Name |
|
Concept
|
Colitis
|
|
Concept
|
Colitis, Ulcerative
|
|
Academic Article
|
Crohn's disease.
|
|
Academic Article
|
Surveillance colonoscopy in ulcerative colitis: is the message loud and clear?
|
|
Academic Article
|
Protection from primary sclerosing cholangitis: smoke trails of just coattails?
|
|
Academic Article
|
Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial.
|
|
Academic Article
|
Cyclosporin for severe ulcerative colitis: a user's guide.
|
|
Academic Article
|
Protein-losing enteropathy and massive pulmonary embolism in a patient with giant inflammatory polyposis and quiescent ulcerative colitis.
|
|
Academic Article
|
Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: a dose-ranging study. U.S. Budesonide enema study group.
|
|
Academic Article
|
No butts about it: put the fire out by lighting up.
|
|
Academic Article
|
A comparison of the quality of life in patients with severe ulcerative colitis after total colectomy versus medical treatment with intravenous cyclosporin.
|
|
Academic Article
|
Leukotrienes in ulcerative colitis: results of a multicenter trial of a leukotriene biosynthesis inhibitor, MK-591.
|
|
Academic Article
|
Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1.
|
|
Academic Article
|
Medical therapy for inflammatory bowel disease.
|
|
Academic Article
|
Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety.
|
|
Academic Article
|
Pneumocystis carinii pneumonia during cyclosporine therapy for ulcerative colitis.
|
|
Academic Article
|
Dose-ranging study of mesalamine (PENTASA) enemas in the treatment of acute ulcerative proctosigmoiditis: results of a multicentered placebo-controlled trial. The U.S. PENTASA Enema Study Group.
|
|
Academic Article
|
A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis.
|
|
Academic Article
|
Primary sclerosing cholangitis and ulcerative colitis: potential cofactors in the dysplasia sequence.
|
|
Academic Article
|
Non-Hodgkin's lymphoma presenting nine years after ileal-pouch ileoanal anastomosis for ulcerative colitis.
|
|
Academic Article
|
The menstrual cycle and its effect on inflammatory bowel disease and irritable bowel syndrome: a prevalence study.
|
|
Academic Article
|
Balsalazide led to greater remission rates and tolerance than mesalamine in acute ulcerative colitis.
|
|
Academic Article
|
Surveying surveillance: are gastroenterologists consistently inconsistent, inconsistently consistent, or poorly educated?
|
|
Academic Article
|
Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease.
|
|
Academic Article
|
Update on medical management of inflammatory bowel disease: ulcerative colitis.
|
|
Academic Article
|
Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis.
|
|
Academic Article
|
Long-term use of mesalamine (Rowasa) suppositories in remission maintenance of ulcerative proctitis.
|
|
Academic Article
|
Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study.
|
|
Academic Article
|
Efficacy and safety of oral ridogrel in the treatment of ulcerative colitis: two multicentre, randomized, double-blind studies.
|
|
Academic Article
|
Systematic review: the pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro-drugs used in the management of ulcerative colitis.
|
|
Academic Article
|
First two patients with ulcerative colitis who developed classical thrombotic thrombocytopenic purpura successfully treated with medical therapy and plasma exchange.
|
|
Academic Article
|
Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trial.
|
|
Academic Article
|
HLA disparity determines disease activity through pregnancy in women with inflammatory bowel disease.
|
|
Academic Article
|
Can cyclosporine go it alone in severe ulcerative colitis?
|
|
Academic Article
|
Review article: the long-term management of ulcerative colitis.
|
|
Academic Article
|
Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis.
|
|
Academic Article
|
Treatment of ulcerative colitis with balsalazide: response to Drs Johnson, Green, and Pruitt.
|
|
Academic Article
|
The state of the art in the management of inflammatory bowel disease.
|
|
Academic Article
|
Caution in the interpretation of safety and efficacy differences in clinical trials comparing aminosalicylates for ulcerative colitis.
|
|
Academic Article
|
Unemployment and disability in patients with moderately to severely active Crohn's disease.
|
|
Academic Article
|
Review article: aminosalicylates in inflammatory bowel disease.
|
|
Academic Article
|
Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort.
|
|
Academic Article
|
Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis.
|
|
Academic Article
|
Superior mesenteric vein thrombosis after colectomy in a patient with Crohn's disease.
|
|
Academic Article
|
Emerging biologic therapies in inflammatory bowel disease.
|
|
Academic Article
|
New lessons: classic treatments, expanding options in ulcerative colitis.
|
|
Academic Article
|
Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
|
|
Academic Article
|
A randomized, placebo-controlled, phase II study of tetomilast in active ulcerative colitis.
|
|
Academic Article
|
Feasibility and utility of an electronic diary to assess self-report symptoms in patients with inflammatory bowel disease.
|
|
Academic Article
|
The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients.
|
|
Academic Article
|
International forum on ulcerative colitis. Risk selection aspects of ulcerative colitis.
|
|
Academic Article
|
Comparative analysis of the in vitro prosecretory effects of balsalazide, sulfasalazine, olsalazine, and mesalamine in rabbit distal ileum.
|
|
Academic Article
|
Dysplasia and cancer complicating strictures in ulcerative colitis.
|
|
Academic Article
|
Review article: evolving concepts in treatment and disease modification in ulcerative colitis.
|
|
Academic Article
|
Controversies with aminosalicylates in inflammatory bowel disease.
|
|
Academic Article
|
Therapy of ulcerative colitis.
|
|
Academic Article
|
A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis.
|
|
Academic Article
|
The absence of an association between oral contraceptive use and ulcerative colitis in patients.
|
|
Academic Article
|
Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab.
|
|
Academic Article
|
Phenotype-stratified genetic linkage study demonstrates that IBD2 is an extensive ulcerative colitis locus.
|
|
Academic Article
|
Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis.
|
|
Academic Article
|
Smoking and inflammatory bowel disease: trends in familial and sporadic cohorts.
|
|
Academic Article
|
Long term efficacy and safety of allopurinol and azathioprine or 6-mercaptopurine in patients with inflammatory bowel disease.
|
|
Academic Article
|
Testing nicotine gum for ulcerative colitis patients. Experience with single-patient trials.
|
|
Academic Article
|
Risks and benefits of combining immunosuppressives and biological agents in inflammatory bowel disease: is the synergy worth the risk?
|
|
Academic Article
|
The role of biologics in ulcerative colitis.
|
|
Academic Article
|
An evidence-based systematic review on medical therapies for inflammatory bowel disease.
|
|
Academic Article
|
Tumor-associated glycoprotein (TAG-72) expression in ulcerative colitis.
|
|
Academic Article
|
Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial.
|
|
Academic Article
|
Colon cancer surveillance in chronic ulcerative colitis: historical cohort study.
|
|
Academic Article
|
Calcineurin inhibition in severe ulcerative colitis: lost in translation?
|
|
Academic Article
|
A phase I study of visilizumab, a humanized anti-CD3 monoclonal antibody, in severe steroid-refractory ulcerative colitis.
|
|
Academic Article
|
Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab.
|
|
Academic Article
|
Treatment of diarrhea in patients with inflammatory bowel disease: concepts and cautions.
|
|
Academic Article
|
Update on the management of ulcerative colitis.
|
|
Academic Article
|
Efficacy of topical 5-aminosalicylates in preventing relapse of quiescent ulcerative colitis: a meta-analysis.
|
|
Academic Article
|
What changes in inflammatory bowel disease management can be implemented today?
|
|
Academic Article
|
Abatacept for Crohn's disease and ulcerative colitis.
|
|
Academic Article
|
Treat the patient or treat the disease?
|
|
Academic Article
|
Two brothers with skewed thiopurine metabolism in ulcerative colitis treated successfully with allopurinol and mercaptopurine dose reduction.
|
|
Academic Article
|
Management of inflammatory bowel disease: past, present and future.
|
|
Academic Article
|
Smoking and inflammatory bowel disease in families.
|
|
Academic Article
|
Assessing response and loss of response to biological therapies in IBD.
|
|
Academic Article
|
miR-143 and miR-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenes.
|
|
Academic Article
|
Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis.
|
|
Academic Article
|
Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS).
|
|
Academic Article
|
The management of ulcerative colitis.
|
|
Academic Article
|
Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Pentasa UC Maintenance Study Group.
|
|
Academic Article
|
Update on the etiology, pathogenesis and diagnosis of ulcerative colitis.
|
|
Academic Article
|
Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial.
|
|
Academic Article
|
Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis.
|
|
Academic Article
|
Delayed-release oral mesalamine 4.8 g/day (800-mg tablet) is effective for patients with moderately active ulcerative colitis.
|
|
Academic Article
|
Emerging issues in ulcerative colitis and ulcerative proctitis: individualizing treatment to maximize outcomes.
|
|
Academic Article
|
Hazard rates for dysplasia and cancer in ulcerative colitis. Results from a surveillance program.
|
|
Academic Article
|
Infliximab for induction and maintenance therapy for ulcerative colitis.
|
|
Academic Article
|
Selected individual therapeutic problems in inflammatory bowel disease.
|
|
Academic Article
|
Association between higher predicted serum vitamin D levels and reduced incidence of inflammatory bowel diseases.
|
|
Academic Article
|
Pattern and prognosis of liver function test abnormalities during parenteral nutrition in inflammatory bowel disease.
|
|
Academic Article
|
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?
|
|
Academic Article
|
Optimal timing of colonoscopy to screen for cancer in ulcerative colitis.
|
|
Academic Article
|
5-ASA enema therapy.
|
|
Academic Article
|
Pilot feasibility studies of leukocytapheresis with the Adacolumn Apheresis System in patients with active ulcerative colitis or Crohn disease.
|
|
Academic Article
|
Acute leukemia following inflammatory bowel disease.
|
|
Academic Article
|
A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis.
|
|
Academic Article
|
Prevalence and incidence of inflammatory bowel disease in family members.
|
|
Academic Article
|
Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis.
|
|
Academic Article
|
Cigarette smoking and ulcerative colitis: a case-control study.
|
|
Academic Article
|
Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group.
|
|
Academic Article
|
Delayed-release oral mesalamine 4.8 g/day (800 mg tablets) compared to 2.4 g/day (400 mg tablets) for the treatment of mildly to moderately active ulcerative colitis: The ASCEND I trial.
|
|
Academic Article
|
Lack of association between oral contraceptive use and ulcerative colitis.
|
|
Academic Article
|
Nicotine for colitis--the smoke has not yet cleared.
|
|
Academic Article
|
Cyclosporine in severe ulcerative colitis refractory to steroid therapy.
|
|
Academic Article
|
Conventional treatment in inflammatory bowel disease--recent trends. Immunosuppressants and biologic agents: should they or need they be used together? How to use immunosuppressive therapy better (and safer) tomorrow?
|
|
Academic Article
|
Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. A case-control study.
|
|
Academic Article
|
Passive smoking is associated with an increased risk of developing inflammatory bowel disease in children.
|
|
Academic Article
|
Inflammatory bowel disease.
|
|
Academic Article
|
pANCA and classification resistance in ulcerative colitis.
|
|
Academic Article
|
Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial.
|
|
Academic Article
|
Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis.
|
|
Academic Article
|
Can we treat ulcerative colitis with nutritional supplements?
|
|
Academic Article
|
Commentary: pre-operative use of anti-TNF-a agents and the risk of post-operative complications in patients with ulcerative colitis.
|
|
Academic Article
|
Morbidity of subtotal colectomy in patients with severe ulcerative colitis unresponsive to cyclosporin.
|
|
Academic Article
|
Mesalamine capsules enhance the quality of life for patients with ulcerative colitis.
|
|
Academic Article
|
Intravenous cyclosporin in ulcerative colitis: a five-year experience.
|
|
Academic Article
|
New steroids for IBD: progress report.
|
|
Academic Article
|
Medical therapy for ulcerative colitis 2004.
|
|
Academic Article
|
Infliximab or cyclosporine for severe ulcerative colitis.
|
|
Academic Article
|
Review article: high-dose aminosalicylates to induce and maintain remissions in ulcerative colitis.
|
|
Academic Article
|
Medical therapy for ulcerative colitis.
|
|
Academic Article
|
Mea culpa.
|
|
Academic Article
|
Assessment of non-cirrhotic portal hypertension associated with thiopurine therapy in inflammatory bowel disease.
|
|
Academic Article
|
Long-term infliximab maintenance therapy for ulcerative colitis: the ACT-1 and -2 extension studies.
|
|
Academic Article
|
Early symptomatic response and mucosal healing with mesalazine rectal suspension therapy in active distal ulcerative colitis--additional results from two controlled studies.
|
|
Academic Article
|
Low-dose smoking resumption in ex-smokers with refractory ulcerative colitis.
|
|
Academic Article
|
Medical therapy of ulcerative colitis.
|
|
Academic Article
|
Reply to Dr Kountouras et al.'s letter.
|
|
Academic Article
|
Gene signature distinguishes patients with chronic ulcerative colitis harboring remote neoplastic lesions.
|
|
Academic Article
|
Safety and effectiveness of long-term allopurinol-thiopurine maintenance treatment in inflammatory bowel disease.
|
|
Academic Article
|
Long-term treatment of patients with a history of ulcerative colitis who develop gastritis and pan-enteritis after colectomy.
|
|
Academic Article
|
Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis.
|
|
Academic Article
|
Reliability and initial validation of the ulcerative colitis endoscopic index of severity.
|
|
Academic Article
|
In vitro sensitivity assays and clinical response to glucocorticoids in patients with inflammatory bowel disease.
|
|
Academic Article
|
Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study.
|
|
Academic Article
|
Vedolizumab as induction and maintenance therapy for ulcerative colitis.
|
|
Academic Article
|
Still in pursuit.
|
|
Academic Article
|
Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases.
|
|
Academic Article
|
The Impact of Clinical Information on the Assessment of Endoscopic Activity: Characteristics of the Ulcerative Colitis Endoscopic Index Of Severity [UCEIS].
|
|
Academic Article
|
Emerging Treatment Options in Mild to Moderate Ulcerative Colitis.
|
|
Academic Article
|
Surveillance of IBD Using High Definition Colonoscopes Does Not Miss Adenocarcinoma in Patients with Low-grade Dysplasia.
|
|
Academic Article
|
The Crohn's Disease-Ulcerative Colitis Clinical Appraisal.
|
|
Academic Article
|
Oral or Topical 5-ASA in Ulcerative Colitis.
|
|
Academic Article
|
Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis.
|
|
Academic Article
|
Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitis.
|
|
Academic Article
|
Interpreting Registrational Clinical Trials of Biological Therapies in Adults with Inflammatory Bowel Diseases.
|
|
Academic Article
|
Development of an index to define overall disease severity in IBD.
|
|
Academic Article
|
Vitamin D Levels and Outcomes in Inflammatory Bowel Disease-Which is the Chicken and Which is the Egg?
|
|
Academic Article
|
Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes.
|
|
Academic Article
|
Optimizing pharmacologic management of inflammatory bowel disease.
|
|
Academic Article
|
miR-4728-3p Functions as a Tumor Suppressor in Ulcerative Colitis-associated Colorectal Neoplasia Through Regulation of Focal Adhesion Signaling.
|
|
Academic Article
|
Assessment of peri-polyp biopsy specimens of flat mucosa in patients with inflammatory bowel disease.
|
|
Academic Article
|
Long-term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis.
|
|
Academic Article
|
Checkpoint Inhibitor-Induced Colitis: A New Type of Inflammatory Bowel Disease?
|
|
Academic Article
|
Clinical Response and Complications are not Associated with Drug Levels in Patients with Severe Ulcerative Colitis on IV Cyclosporine Induction Therapy.
|
|
Academic Article
|
A randomized trial of the effects of the no-carrageenan diet on ulcerative colitis disease activity.
|
|
Academic Article
|
Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases-A Clinical Practice Update: Commentary.
|
|
Academic Article
|
Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis.
|
|
Academic Article
|
Prevalence and screening for anaemia in mild to moderate Crohn's disease and ulcerative colitis in the United States, 2010-2014.
|
|
Academic Article
|
Efficacy and Follow-up of Segmental or Subtotal Colectomy in Patients With Colitis-Associated Neoplasia.
|
|
Academic Article
|
Neutrophil-induced genomic instability impedes resolution of inflammation and wound healing.
|
|
Academic Article
|
Rapid Changes in Laboratory Parameters and Early Response to Adalimumab: A Pooled Analysis From Patients With Ulcerative Colitis in Two Clinical Trials.
|
|
Academic Article
|
IM-UNITI: Three-year Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's Disease.
|
|
Academic Article
|
Checkpoint Inhibitor-Induced Colitis.
|
|
Academic Article
|
Reply to critique of "A randomized trial of the effects of the no-carrageenan diet on ulcerative colitis disease activity".
|
|
Academic Article
|
Time to Symptom Resolution in Ulcerative Colitis With Multimatrix Mesalazine Treatment: A Pooled Analysis.
|
|
Academic Article
|
Segmental Histological Normalisation Occurs in Ulcerative Colitis but Does Not Improve Clinical Outcomes.
|
|
Academic Article
|
Drug-Induced Colitis.
|
|
Academic Article
|
Association between inflammatory bowel disease and prostate cancer: A large-scale, prospective, population-based study.
|
|
Academic Article
|
Long-Term Efficacy and Safety of Ozanimod in Moderately to Severely Active Ulcerative Colitis: Results From the Open-Label Extension of the Randomized, Phase 2 TOUCHSTONE Study.
|
|
Academic Article
|
Neutrophils Alter DNA Repair Landscape to Impact Survival and Shape Distinct Therapeutic Phenotypes of Colorectal Cancer.
|
|
Academic Article
|
The Guide to Guidelines in Ulcerative Colitis: Interpretation and Appropriate Use in Clinical Practice.
|
|
Academic Article
|
Posttraumatic Stress in Patients With Inflammatory Bowel Disease: Prevalence and Relationships to Patient-Reported Outcomes.
|
|
Academic Article
|
Epidemiology of Colorectal Cancer in Inflammatory Bowel Disease - the Evolving Landscape.
|
|
Academic Article
|
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.
|
|
Academic Article
|
Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study.
|
|
Academic Article
|
Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study.
|
|
Academic Article
|
P035 Ozanimod for Moderate-to-Severe Ulcerative Colitis: North American Population Results During Induction and Maintenance in the Phase 3 True North Study.
|
|
Academic Article
|
Recommendations on the Appropriate Management of Steroids and Discharge Planning During and After Hospital Admission for Moderate-Severe Ulcerative Colitis: Results of a RAND Appropriateness Panel.
|
|
Academic Article
|
A critical review of ozanimod for the treatment of adults with moderately to severely active ulcerative colitis.
|
|
Academic Article
|
CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease.
|
|
Academic Article
|
Editorial: safety and efficacy of infliximab and corticosteroids in checkpoint inhibitor-induced colitis.
|
|
Academic Article
|
Immune Checkpoint Inhibitor Enterocolitis vs Idiopathic Inflammatory Bowel Disease.
|
|
Academic Article
|
Atovaquone attenuates experimental colitis by reducing neutrophil infiltration of colonic mucosa.
|
|
Academic Article
|
Noninvasive Targeted Crohn Disease Management by Combining Endoscopic Healing Index and Therapeutic Drug Monitoring.
|
|
Academic Article
|
Safety, Pharmacokinetics, and Efficacy of Olorinab, a Peripherally Acting, Highly Selective, Full Agonist of the Cannabinoid Receptor 2, in a Phase 2a Study of Patients With Chronic Abdominal Pain Associated With Crohn's Disease.
|
|
Academic Article
|
The evolving role of JAK inhibitors in the treatment of inflammatory bowel disease.
|
|
Academic Article
|
A randomised, double-blind, placebo-controlled study of the LAG-3-depleting monoclonal antibody GSK2831781 in patients with active ulcerative colitis.
|
|
Academic Article
|
P035 Ozanimod for Moderate-to-Severe Ulcerative Colitis: North American Population Results During Induction and Maintenance in the Phase 3 True North Study.
|
|
Academic Article
|
Neuroimmune Modulation Through Vagus Nerve Stimulation Reduces Inflammatory Activity in Crohn's Disease Patients: A Prospective Open-label Study.
|
|
Academic Article
|
Baseline TREM-1 Whole Blood Gene Expression Does Not Predict Response to Adalimumab Treatment in Patients with Ulcerative Colitis or Crohn's Disease in the SERENE Studies.
|
|
Academic Article
|
Post-traumatic stress disorder symptoms are frequent among inflammatory bowel disease patients of South Asian descent-A case-control study.
|
|
Academic Article
|
MMX Mesalamine for Induction and Maintenance Therapy in Mild-to-Moderate Ulcerative Colitis.
|
|
Academic Article
|
Efficacy and Safety of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 Antibody Ontamalimab in Patients with Moderate-to-Severe Ulcerative Colitis or Crohn's Disease.
|
|
Academic Article
|
Tissue-specific reprogramming leads to angiogenic neutrophil specialization and tumor vascularization in colorectal cancer.
|
|
Academic Article
|
Highlights in Ulcerative Colitis From Digestive Disease Week 2023: Commentary.
|